Figure 4.

Likelihood ratio test for the incremental prognostic value of a significant change in LV GLS and LARS. The addition of a 20% change in LV GLS and a 5% change in LARS to a baseline clinical model is associated with significant increases in the χ² value. *The baseline model includes age, sex, arterial hypertension, diabetes mellitus, dyslipidaemia, ischaemic aetiology for heart failure, estimated glomerular filtration rate, New York Heart Association functional class III–IV, baseline left ventricular end-systolic volume, baseline left atrium volume index, baseline left atrial reservoir strain, baseline left ventricular global longitudinal strain, and tricuspid annular plane systolic excursion. LARS, left atrial reservoir strain; LV ESV, left ventricular end-systolic volume; LV GLS, left ventricular global longitudinal strain.